Document is current
Any future updates will be listed below
-
Authors
Ha, Dat P.
Shin, Woo-Jin
Liu, Ze
Doche, Michael E.
Lau, Roy
Leli, Nektaria Maria
Conn, Crystal S.
Russo, Mariangela
Lorenzato, Annalisa
Koumenis, Constantinos
Yu, Min
Mumenthaler, Shannon M.
Lee, Amy S. https://orcid.org/0000-0002-0378-5443
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01 CA027607)
National Institutes of Health (R01 CA238029)
National Institutes of Health (R01 CA238029)
National Institutes of Health (R01 CA238029)
Italian Association for Cancer Research (MFAG 2021-ID 26439)
- License Information
-
More Information
Article History
Received: 16 April 2024
Accepted: 27 August 2024
First Online: 6 September 2024
Declarations
:
: All animal experiments were performed in accordance with protocols and guidelines approved by the Institutional Animal Care and Use Committee at the University of Southern California (IACUC Protocol Number: 21091).
: Not applicable.
: A.S.L. is a scientific advisory board member of BiPER Therapeutics. M.Y. is the founder and president of CanTraCer Biosciences Inc. The other co-authors declare no competing interests.
